Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase III study of JCR Pharmaceuticals' JR-141 for Hunter syndrome begins

Aug. 10, 2018

Basilea Pharmaceutica starts second registrational phase III study of ceftobiprole

Aug. 10, 2018

FDA approves Arakoda for prevention of malaria

Aug. 10, 2018

Global phase III trial of Celltrion's bevacizumab biosimilar begins

Aug. 10, 2018

Petrovax Pharm's 4-valeant influenza vaccine --Grippol Quadrivalent-- approved in Russia

Aug. 10, 2018

I-Mab cleared to conduct clinical trial of TJ-103 in China

Aug. 10, 2018

New review on glyphosate evaluating mechanisms, regulatory framework and research prospects

Aug. 10, 2018

Gemphire Therapeutics halts pediatric NAFLD study of gemcabene

Aug. 10, 2018

Inhibitors of "undruggable" enzymes induce tumor arrest

Aug. 10, 2018

Epilepsy-associated de novo variants in GABRs alter GABA(A) receptor function

Aug. 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...